Drugmaker shares plummet ahead of FDA meeting on antibiotic

Wednesday, November 2, 2016 - 14:21 in Health & Medicine

WASHINGTON (AP) -- Shares of drugmaker Cempra Inc. plunged Wednesday after federal regulators raised concerns about potential liver toxicity risks with its closely-watched experimental antibiotic....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net